SPONSOR

Maastricht University Medical Center

Total Trials

Recruiting

Phases

Phase 4, Phase 3

Conditions studied: Pulmonary Disease, Chronic Obstructive Breast Cancer Reconstructive Surgery Breast Reconstruction Actinic Keratoses Exercise Metabolism Sepsis Bloodstream Infection Lymphedema, Secondary Lymphedema of Upper Limb

Maastricht University Medical Center is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Pulmonary Disease, Chronic Obstructive, Breast Cancer, Reconstructive Surgery, Breast Reconstruction.

The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Maastricht University Medical Center

How many clinical trials has Maastricht University Medical Center sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by Maastricht University Medical Center, of which 15 are actively recruiting participants. These trials cover conditions including Pulmonary Disease, Chronic Obstructive, Breast Cancer, Reconstructive Surgery. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Maastricht University Medical Center research focus on?

Maastricht University Medical Center clinical trials span Pulmonary Disease, Chronic Obstructive, Breast Cancer, Reconstructive Surgery, Breast Reconstruction, Actinic Keratoses, and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Maastricht University Medical Center clinical trial?

To participate in a Maastricht University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Maastricht University Medical Center trials with current recruitment status updated daily.

Maastricht University Medical Center

Frequently Asked Questions — Maastricht University Medical Center

Clinical Trials by Maastricht University Medical Center

Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)

AFT: Introduction of a Full Breast Reconstructive Method

Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

The Effect of Acute Ketone Monoester Supplementation on Glucose Oxidation During Exercise

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema

Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer Patients

Biobank Clinical Genetics Maastricht (KG01)

Non Invasive Cancer Test (NICT): a Proof of Principle Study.

PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

Frequency of Interrupting Sitting and Cognitive Function

Multi-contrast Versus Multi-sequence Carotid MRI

Prevent CardioKids

Bleeding Disorder of Unknown Cause in the Netherlands